Pioglar MF 7.5 mg/500 mg Tablet MR
By Pioglar MF
Rx
10 Tablet MR in a Strip

Composition
Pioglitazone(7.5mg) + Metformin(500mg)

Manufacturer - Sun Pharmaceutical Industries Ltd
Plot no 107/108,Namli block , Ranipool, East Sikkim 737135

Expires on or after
October, 2025

liver
Caution should be taken when using Pioglar MF 7.5 mg/500 mg Tablet MR in patients with liver disease. It may be necessary to adjust the dose of the medication, so it is important to consult your doctor before use. Typically, Pioglar MF 7.5 mg/500 mg Tablet MR is initiated at a low dose for patients with mild to moderate liver disease. However, it is not advisable to use this medication in individuals with severe liver disease.

kidney
Pioglar MF 7.5 mg/500 mg Tablet MR should be used carefully in patients with kidney issues. Dose adjustment may be necessary. Avoid in severe cases. Monitor kidney function regularly during use. Consult your doctor for guidance.

alcohol
It is not safe to drink alcohol while taking Pioglar MF 7.5 mg/500 mg Tablet MR. You should consult your doctor when consuming alcohol with Pioglar MF 7.5 mg/500 mg Tablet MR.

driving
When your blood sugar levels are too low or too high, your driving performance may be impacted. It is advisable not to drive if you experience such symptoms.

pregnancy
Pioglar MF 7.5 mg/500 mg Tablet MR may not be safe to use during pregnancy. Animal studies show risks to the developing baby. Consult your doctor about benefits and risks before using it.

breastfeeding
Pioglar MF 7.5 mg/500 mg Tablet MR is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI DIABETIC |
Action Class | - |
₹65.5
Inclusive of all taxes
Content verified by

Dr. Upasana Bhatia
MBBS - General Medicine
Last update on 11-Feb-2025